World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
23812
World Ranking
17992
National Ranking
8968

Mark S. Talamonti publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Mark S. Talamonti sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 318 publications — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Mark S. Talamonti D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Mark S. Talamonti sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 78 D-Index — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Mark S. Talamonti is affiliated with NorthShore University HealthSystem in the United States. Their research spans medicine with a focus on immunology and microbiology, encompassing 177 and 45 publications in these primary fields, respectively.

Their subfields of study include dermatology, immunology, surgery, physiology, and immunology and allergy. Dermatology and skin diseases represent a central topic, supported by 88 publications. Additional research interests cover psoriasis treatment and pathogenesis, asthma and respiratory diseases, allergic rhinitis and sensitization, pancreatic and hepatic oncology research, surgical simulation and training, and autoimmune bullous skin diseases.

Mark S. Talamonti has published in multiple scientific venues, frequently contributing to:

  • Expert Opinion on Biological Therapy
  • Journal of Clinical Medicine
  • HPB
  • Journal of the European Academy of Dermatology and Venereology
  • Dermatology and Therapy

Recent notable papers include:

  • "Virtual Surgical Fellowship Recruitment During COVID-19 and Its Implications for Resident/Fellow Recruitment in the Future," 2020, Annals of Surgical Oncology
  • "Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy," 2023, JAMA
  • "Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study," 2020, Journal of the European Academy of Dermatology and Venereology
  • "Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment: a case series and review of the literature," 2020, Expert Opinion on Biological Therapy
  • "Quality of Life and Psychological Impact in Patients with Atopic Dermatitis," 2021, Journal of Clinical Medicine

Their collaborative work involves frequent coauthors such as:

  • Marco Galluzzo
  • Luca Bianchi
  • Claudia Paganini
  • Melissa E. Hogg
  • Concetta Potenza

Best Publications

  • Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma

    Richard A. Moffitt;Raoud Marayati;Elizabeth L. Flate;Keith E. Volmar

  • Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement.

    Mark P. Callery;Kenneth J. Chang;Elliot K. Fishman;Mark S. Talamonti

  • Extent of surgery affects survival for papillary thyroid cancer.

    Karl Y. Bilimoria;David J. Bentrem;Clifford Y. Ko;Clifford Y. Ko;Andrew K. Stewart

  • Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years.

    Karl Y Bilimoria;David Jason Bentrem;Jeffrey D Wayne;Clifford Y. Ko;Clifford Y. Ko

  • Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer

    Mark S. Talamonti;Mark S. Roh;Steven A. Curley;Gary E. Gallick

  • National Failure to Operate on Early Stage Pancreatic Cancer

    Karl Y. Bilimoria;David J. Bentrem;Clifford Y. Ko;Clifford Y. Ko;Andrew K. Stewart

  • Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database.

    Karl Y Bilimoria;Karl Y Bilimoria;David Jason Bentrem;Clifford Y. Ko;Clifford Y. Ko;Jamie Ritchey

  • Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101.

    Matthew H.G. Katz;Qian Shi;Syed A. Ahmad;Joseph M. Herman

  • Left-sided pancreatectomy: a multicenter comparison of laparoscopic and open approaches.

    David A. Kooby;David A. Kooby;Theresa Gillespie;Theresa Gillespie;David Jason Bentrem;Attila Nakeeb

  • Postoperative complications reduce adjuvant chemotherapy use in resectable pancreatic cancer

    Ryan P. Merkow;Karl Y. Bilimoria;James S. Tomlinson;Jennifer L. Paruch;Jennifer L. Paruch

  • Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients.

    Karl Y. Bilimoria;Mark S. Talamonti;James S. Tomlinson;Andrew K. Stewart

  • Wait times for cancer surgery in the United States: Trends and predictors of delays

    Karl Y Bilimoria;Clifford Y. Ko;Clifford Y. Ko;James S. Tomlinson;Andrew K. Stewart

  • Learning sentinel node biopsy: results of a prospective randomized trial of two techniques.

    Monica Morrow;Alfred W. Rademaker;Kevin P. Bethke;Mark S. Talamonti

  • Primary cancers of the small bowel: analysis of prognostic factors and results of surgical management.

    Mark S. Talamonti;Laura H. Goetz;Sambasiva Rao;Raymond J. Joehl

  • A Multi-Institutional Phase II Trial of Preoperative Full-Dose Gemcitabine and Concurrent Radiation for Patients With Potentially Resectable Pancreatic Carcinoma

    Mark S. Talamonti;William Small;Mary F. Mulcahy;Jeffrey D. Wayne

  • Multimodality therapy for pancreatic cancer in the U.S. : utilization, outcomes, and the effect of hospital volume.

    Karl Y. Bilimoria;Karl Y. Bilimoria;David J. Bentrem;Clifford Y. Ko;Clifford Y. Ko;James S. Tomlinson

  • Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors.

    Katherine A. Yao;Mark S. Talamonti;Albert Nemcek;Peter Angelos

  • A multi-institutional comparison of perioperative outcomes of robotic and open pancreaticoduodenectomy

    Amer H. Zureikat;Lauren M. Postlewait;Yuan Liu;Theresa W. Gillespie

  • A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma.

    Jeran K. Stratford;David J. Bentrem;Judy M. Anderson;Cheng Fan

  • Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres--safety, efficacy, and survival.

    Kent T. Sato;Robert J. Lewandowski;Mary F. Mulcahy;Bassel Atassi

Frequent Co-Authors

David J. Bentrem
David J. Bentrem Northwestern University
Karl Y. Bilimoria
Karl Y. Bilimoria Indiana University
Clifford Y. Ko
Clifford Y. Ko University of California, Los Angeles
Thomas E. Adrian
Thomas E. Adrian Northwestern University
David P. Winchester
David P. Winchester American College of Surgeons
Mary F. Mulcahy
Mary F. Mulcahy Northwestern University
Al B. Benson
Al B. Benson Northwestern University
Henry N. Wagner
Henry N. Wagner Penn State Cancer Institute
Alfred W. Rademaker
Alfred W. Rademaker Northwestern University
David A. Kooby
David A. Kooby Emory University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in medicine but want alternative education routes or careers, there are several online pathways to consider. For nurses aiming to advance quickly, the shortest DNP program provides a direct, efficient route to a Doctor of Nursing Practice, opening new clinical and leadership roles.

Some students prefer to enter the healthcare field as soon as possible. A fast track medical program, such as accelerated Licensed Practical Nurse (LPN) courses, offers a quick start for those who want hands-on patient care experience without the long commitment of medical school.

Mental health careers are also in high demand. The fast track mental health nursing programs allow registered nurses to specialize as psychiatric mental health nurse practitioners in less time, addressing urgent needs in mental healthcare.

Not all medical careers require direct patient care. If you’re interested in health policy, business, or management, the cheapest online healthcare administration degree can provide a flexible and affordable way to move into leadership and administrative roles in hospitals and related organizations.

Best Scientists Citing Mark S. Talamonti

Trending Scientists

Recently Published Articles